Join
Live feed
·
INSIDERFilingvia Quantisnow
Silverback Therapeutics Inc. logo

Fitzpatrick Alexander A bought $319,954 worth of shares (86,258 units at $3.71), increasing direct ownership by 2,905% to 89,227 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SBTX· Silverback Therapeutics Inc.
Consumer Discretionary
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SBTX (Silverback Therapeutics Inc.) and more on Quantisnow.